LNA SANTE Stock: price and management transactions · France · AMFSource id RS00004382 ISIN ISIN FR0004170017FR · AMF Mcap €369.6M 医疗与制药 Follow the LNA SANTE stock price and the full insider trade history of the company, a listed equity based in France. Shares trade on the FR market, under the oversight of AMF. Operating in the Healthcare & Pharma sector, LNA SANTE has logged 140 public disclosures. Market capitalisation: €369.6m. The latest transaction was disclosed on 29 June 2026 (Acquisition). Among the most active insiders: SMABTP. All data is free.
Analyst consensus: bullish or bearish? Analysts rate LNA SANTE Strong Buy (bullish), based on 4 analysts. Average price target: €40.00.
Fundamental score
Ranked 6,337 of 29,055 companies
FCF yld 25%
Earn yld 7.0%
EV/EBITDA 8.1x
ROE 7.7%
Gross mgn 88%
Net mgn 2.6%
Debt/EBITDA 5.9x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
All Executives140 Thresholds0 Prospectus0 Other0
Declarations 140 total
▲ Chairman of the Board · Executives · 23 Jun 2026
769 shares @ €32.90 0.0072% mcap 0.1% of flow Action Euronext ParisISIN ISIN FR00041700172026DD1123327 Canonical exit: 21 Sept 2026 (T+90) ▲ Chairman of the Board · Executives · 18 Jun 2026
651 shares @ €32.994 0.0063% mcap 0.1% of flow Action Euronext ParisISIN ISIN FR00041700172026DD1122318 Canonical exit: 16 Sept 2026 (T+90) ▲ Chairman of the Board · Executives · 12 Jun 2026
200 shares @ €33.00 0.0019% mcap 0.0% of flow Action Euronext ParisISIN ISIN FR00041700172026DD1121513 Canonical exit: 10 Sept 2026 (T+90) ▲ Chairman of the Board · Executives · 4 Jun 2026
1,449 shares @ €33.00 0.014% mcap 0.2% of flow Action Euronext ParisISIN ISIN FR00041700172026DD1119817 Canonical exit: 2 Sept 2026 (T+90) ▲ Chairman of the Board · Executives · 14 May 2026
856 shares @ €29.50 0.0083% mcap 0.1% of flow Action Euronext ParisISIN ISIN FR00041700172026DD1115357 Canonical exit: 12 Aug 2026 (T+90) ▲ Chairman of the Board · Executives · 7 Apr 2026
233 shares @ €28.00 0.0020% mcap 0.0% of flow Action Euronext ParisISIN ISIN FR00041700172026DD1111804 Canonical exit: 6 Jul 2026 (T+90) ▲ Chairman of the Board · Executives · 21 Apr 2026
2,410 shares @ €28.9954 0.021% mcap 0.3% of flow Action Euronext ParisISIN ISIN FR00041700172026DD1110273 Canonical exit: 20 Jul 2026 (T+90) ▲ Chairman of the Board · Executives · 7 Apr 2026
132,373 shares @ €26.354 1.14% mcap 100.0% of flow Action Euronext ParisISIN ISIN FR00041700172026DD1107254 Canonical exit: 6 Jul 2026 (T+90) ▲ Chairman of the Board · Executives · 27 Mar 2026
132,123 shares @ €26.351 1.14% mcap 14.5% of flow Action Euronext ParisISIN ISIN FR00041700172026DD1105359 Canonical exit: 25 Jun 2026 (T+90) ▲ Président du CA · Executives · 1 Feb 2026
4,333 shares 0
Action Euronext ParisISIN ISIN FR00041700172026DD1092851 Canonical exit: 2 May 2026 (T+90) 4,333 shares 0
Action Euronext ParisISIN ISIN FR00041700172026DD1092855 Canonical exit: 2 May 2026 (T+90) ▲ DGD · Executives · 1 Feb 2026
4,333 shares 0
Action Euronext ParisISIN ISIN FR00041700172026DD1092857 Canonical exit: 2 May 2026 (T+90) ▲ Chairman of the Board · Executives · 19 Sept 2025
3,450 shares @ €29.00 32.5% of flow Action Euronext ParisISIN ISIN FR00041700172025DD1059134 Canonical exit: 18 Dec 2025 (T+90) ▼ Chief Executive Officer · Executives · 19 Sept 2025
3,450 shares @ €29.00 21.7% of flow Action Euronext ParisISIN ISIN FR00041700172025DD1059139 4,166 shares 0
Action Euronext ParisISIN ISIN FR00041700172025DD1013158 Canonical exit: 1 Apr 2025 (T+90) ▲ DGD · Executives · 1 Jan 2025
4,166 shares 0
Action Euronext ParisISIN ISIN FR00041700172025DD1013142 Canonical exit: 1 Apr 2025 (T+90) ▲ Président du CA · Executives · 1 Jan 2025
4,166 shares 0
Action Euronext ParisISIN ISIN FR00041700172025DD1013155 Canonical exit: 1 Apr 2025 (T+90) ▲ DG · Executives · 17 Dec 2024
10 shares @ €22.60 0.0% of flow Action Euronext ParisISIN ISIN FR00041700172024DD1011788 Canonical exit: 17 Mar 2025 (T+90) ▲ DG · Executives · 17 Dec 2024
10 shares @ €22.60 0.0% of flow Action Euronext ParisISIN ISIN FR00041700172024DD1011790 Canonical exit: 17 Mar 2025 (T+90) ▲ Non-Voting Board Observer · Executives · 22 Oct 2024
3,993 shares @ €23.9913 9.1% of flow Action Euronext ParisISIN ISIN FR00041700172024DD1002198 Canonical exit: 20 Jan 2025 (T+90) ▲ Non-Voting Board Observer · Executives · 17 Oct 2024
6,492 shares @ €23.8118 14.6% of flow Action Euronext ParisISIN ISIN FR00041700172024DD1001667 Canonical exit: 15 Jan 2025 (T+90) ▲ Non-Voting Board Observer · Executives · 14 Oct 2024
399 shares @ €23.8278 0.9% of flow Action Euronext ParisISIN ISIN FR00041700172024DD1000962 Canonical exit: 12 Jan 2025 (T+90) ▲ Non-Voting Board Observer · Executives · 9 Oct 2024
24 shares @ €22.60 0.1% of flow Action Euronext ParisISIN ISIN FR00041700172024DD1000305 Canonical exit: 7 Jan 2025 (T+90) ▲ Non-Voting Board Observer · Executives · 4 Oct 2024
102 shares @ €22.8284 0.2% of flow Action Euronext ParisISIN ISIN FR00041700172024DD999778 Canonical exit: 2 Jan 2025 (T+90) ▲ Non-Voting Board Observer · Executives · 2 Oct 2024
2,000 shares @ €23.10 4.4% of flow Action Euronext ParisISIN ISIN FR00041700172024DD999287 Canonical exit: 31 Dec 2024 (T+90) 25 of 140 declarations
Load more (115 remaining) 关于 LNA SANTE LNA Santé 是一家法国医疗保健运营商,专注于支持体弱和依赖性人群,特别是需要长期护理、康复或更复杂医疗支持的老年患者和居民。该集团以 ISIN FR0004170017 在市场上市,历史上被称为 Le Noble Age,于 2016 年更名为 LNA Santé,以更好地反映其作为涵盖医疗社会和临床活动的更广泛医疗保健平台的角色。该公司于 1990 年在南特由 Jean-Paul Siret 创立,他至今仍是公司董事长和创始人。其增长始于一家开创性的养老院 La Chézalière,随后是早期专门针对阿尔茨海默病的设施,之后在 1990 年代末扩展到医疗保健领域。
如今,LNA Santé 运营着多元化的医疗保健业务组合。其主要活动包括养老院和辅助生活设施、急性后期和康复诊所、外科诊所、居家住院、精神卫生保健以及其他本地医疗保健服务。这种多活动模式使集团能够覆盖护理路径中广泛的患者需求,从住宿和日常支持到临床治疗、康复和居家护理。集团强调以人为本的模式,围绕酒店质量、专业护理、运营邻近性、创新和个性化护理计划而建立。
截至 2025 年,LNA Santé 报告拥有 87 家机构,约 9,500 名专业人员和 878 亿欧元的运营收入。因此,它是法国医疗保健领域一个重要的独立参与者,尽管仍小于该行业最大的综合集团。独立性是公司战略和治理的一个决定性特征。LNA Santé 强调其家族所有权结构、受控的股东基础以及员工参与度的提高,员工集体拥有 10% 的股本。
从地理上看,该集团主要集中在法国,在比利时也有既定的业务。这种选择性的足迹与其运营模式以及深化专业知识而非追求不受控制的扩张的愿望相符。LNA Santé 还以其长期战略导向而著称:它已成为一家使命驱动型公司,并加强了与社会、社会和环境绩效相关的承诺。该公司值得注意的特点包括自成立以来的稳步扩张、在阿尔茨海默病护理方面公认的专业知识,以及逐步转向具有更高医疗强度的更高价值医疗保健活动。